Mediterranean Diet Treatment for NAFLD
Sponsored by Antalya Training and Research Hospital
About this trial
Last updated 6 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 6 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Diagnosis of NAFLD
* Body mass index z-score >85th percentile
Exclusion Criteria
* Secondary causes of NAFLD (eg. medication induced)
* Use of weight loss medications
* Diabetes Mellitus
* Other causes of fatty liver disease (eg. Wilson disease, alpha-1 antitrypsin deficiency, auto-immune hepatitis, and viral hepatitis)
